Latest formulary decision guides
-
Formulary decision guideTrajenta® (linagliptin) 5 mg film-coated tablets
Information intended for healthcare professionals only. This promotional formulary decision guide was initiated, funded, and reviewed by Boehringer Ingelheim Limited and Lilly Diabetes Alliance. The format was developed by Guidelines in Practice . View prescribing information Key points on this medicine Linagliptin: ...
-
Formulary decision guide
Formulary decision guide: Ozempic®▼ (semaglutide)
Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Novo Nordisk in a format developed by Guidelines in Practice . It has been reviewed by Novo Nordisk, who commissioned the development of the formulary decision guide. Download the formulary decision guide ...
-
Formulary decision guide
PROSTAP® DCS (leuprorelin acetate)
This formulary decision guide was developed by Guidelines in Practice based on content and funding provided by Takeda UK Ltd.
-
Formulary decision guide
Doublebase Dayleve™ Gel (isopropyl myristate, liquid paraffin)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Dermal Laboratories Ltd in a format developed by Guidelines in Practice . View prescribing information and adverse event reporting here Key points Doublebase Dayleve Gel ...
-
Formulary decision guide
Stalpex (salmeterol xinafoate/fluticasone propionate)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice . View prescribing information here Key points Stalpex is a branded generic inhaled ...
-
Formulary decision guide
Nutramigen™ 1, 2 & 3 with LGG®
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines in Practice . Key points CMA is the most common childhood food allergy affecting 1.9–4.9% of infants ...
-
Formulary decision guide
Soprobec (beclometasone dipropionate) pMDI
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice . View prescribing information here Key points Soprobec is a generic CFC-free beclometasone ...
-
Formulary decision guide
Symbicort® (budesonide/formoterol) for COPD
Information intended for healthcare professionals only. This formulary decision guide was commissioned by AstraZeneca UK Ltd, who had full editorial control, and was produced in a format developed by Guidelines in Practice . Indications Symbicort pMDI 200 μg/6 μg per actuation, pressurised inhalation suspension, Symbicort ...
-
Formulary decision guide
Nutramigen™ PURAMINO™
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mead Johnson Nutrition Ltd in a format developed by Guidelines in Practice . Key points Cow’s milk allergy (CMA) is a common yet complex food allergy, ...
-
Formulary decision guide
Methofill® (methotrexate) Self Inject
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Accord UK Ltd in a format developed by Guidelines in Practice . View prescribing and adverse event reporting information here Key points Methofill ® ...
-
Formulary decision guide
Semglee® ▼ (insulin glargine biosimilar)
This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice .
